VALIDATED EXECUTIVE ENGAGEMENTS
POOL + OUTREACH
382
Number of executives repeatedly engaged by snail & email outreach
INTERACTIONS
76
Interactions with Platform & by Email
PARTICIPANTS
13
Unique # Participated
VALIDATIONS
6
Responses Validated*
* Login to view program details and full enterprise executive list.
DATE
SEP 2020
TABLES
105
PAGES
179
EDITION
7
PRICE
USD $4950
Easy Growth Opportunities Often Go Unnoticed. Find Your "Low Hanging Fruit".
Top Markets for Assisted Reproductive Technology.
Amid the COVID-19 crisis, the global market for Assisted Reproductive Technology estimated at US$24.7 Billion in the year 2020, is projected to reach a revised size of US$43.9 Billion by 2027, growing at a CAGR of 8.6% over the analysis period 2020-2027. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is projected to record a 8.5% CAGR and reach US$27 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Artificial Insemination-Intrauterine Insemination (AI-IUI) segment is readjusted to a revised 8.2% CAGR for the next 7-year period.
The Assisted Reproductive Technology market in the U.S. is estimated at US$7.3 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$7.6 Billion by the year 2027 trailing a CAGR of 8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8% and 7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7% CAGR.
In the global Frozen Embryo Replacement (FER) segment, USA, Canada, Japan, China and Europe will drive the 10.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.7 Billion in the year 2020 will reach a projected size of US$5.3 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$5.1 Billion by the year 2027.We bring years of research experience to this 7th edition of our report. The 179-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Bloom Fertility Centre; Cosmos Biomedical Ltd.; Cryolab Ltd.; European Sperm Bank ApS; Ferring Pharmaceuticals; Irvine Scientific; Microm UK Ltd; ORIGIO A/S; Ovascience Inc.; Parallabs Limited
» End-Use (Fertility Clinics, Hospitals) » Segment (In-Vitro Fertilization (IVF), Artificial Insemination-Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), Other Segments)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World
INSIDER ACCESS PRIVILEGES
Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.
KEY DIFFERENTIATORS
We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.
* A review of 262 off-the-shelf market report publishers worldwide.
WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.
Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.
Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)
A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.
Where relevent and possible we present competitive brands.
Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.
Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.
Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.
We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.
05
| I. INTRODUCTION, METHODOLOGY & REPORT SCOPE |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Global Competitor Market Shares |
| Assisted Reproductive Technology Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 |
| Impact of Covid-19 and a Looming Global Recession |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| 4. GLOBAL MARKET PERSPECTIVE |
| Assisted Reproductive Technology Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027 |
| Assisted Reproductive Technology Global Retrospective Market Scenario in US$ Million by Region/Country: 2012-2019 |
| Assisted Reproductive Technology Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS 2027 |
| In-Vitro Fertilization (IVF) (Segment) World Market by Region/Country in US$ Million: 2020 to 2027 |
| In-Vitro Fertilization (IVF) (Segment) Historic Market Analysis by Region/Country in US$ Million: 2012 to 2019 |
| In-Vitro Fertilization (IVF) (Segment) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Artificial Insemination-Intrauterine Insemination (AI-IUI) (Segment) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027 |
| Artificial Insemination-Intrauterine Insemination (AI-IUI) (Segment) Historic Market Perspective by Region/Country in US$ Million: 2012 to 2019 |
| Artificial Insemination-Intrauterine Insemination (AI-IUI) (Segment) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS 2027 |
| Frozen Embryo Replacement (FER) (Segment) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027 |
| Frozen Embryo Replacement (FER) (Segment) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to 2019 |
| Frozen Embryo Replacement (FER) (Segment) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS 2027 |
| Other Segments (Segment) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027 |
| Other Segments (Segment) Market Historic Review by Region/Country in US$ Million: 2012 to 2019 |
| Other Segments (Segment) Market Share Breakdown by Region/Country: 2012 VS 2020 VS 2027 |
| Fertility Clinics (End-Use) Worldwide Latent Demand Forecasts in US$ Million by Region/Country: 2020-2027 |
| Fertility Clinics (End-Use) Global Historic Analysis in US$ Million by Region/Country: 2012-2019 |
| Fertility Clinics (End-Use) Distribution of Global Sales by Region/Country: 2012 VS 2020 VS 2027 |
| Hospitals (End-Use) Sales Estimates and Forecasts in US$ Million by Region/Country for the Years 2020 through 2027 |
| Hospitals (End-Use) Analysis of Historic Sales in US$ Million by Region/Country for the Years 2012 to 2019 |
| Hospitals (End-Use) Global Market Share Distribution by Region/Country for 2012, 2020, and 2027 |
| III. MARKET ANALYSIS |
| GEOGRAPHIC MARKET ANALYSIS |
| UNITED STATES |
| Market Facts & Figures |
| US Assisted Reproductive Technology Market Share (in %) by Company: 2019 & 2025 |
| United States Assisted Reproductive Technology Market Estimates and Projections in US$ Million by Segment: 2020 to 2027 |
| Assisted Reproductive Technology Market in the United States by Segment: A Historic Review in US$ Million for 2012-2019 |
| United States Assisted Reproductive Technology Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| United States Assisted Reproductive Technology Latent Demand Forecasts in US$ Million by End-Use: 2020 to 2027 |
| Assisted Reproductive Technology Historic Demand Patterns in the United States by End-Use in US$ Million for 2012-2019 |
| Assisted Reproductive Technology Market Share Breakdown in the United States by End-Use: 2012 VS 2020 VS 2027 |
| CANADA |
| Canadian Assisted Reproductive Technology Market Estimates and Forecasts in US$ Million by Segment: 2020 to 2027 |
| Canadian Assisted Reproductive Technology Historic Market Review by Segment in US$ Million: 2012-2019 |
| Assisted Reproductive Technology Market in Canada: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027 |
| Canadian Assisted Reproductive Technology Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 |
| Assisted Reproductive Technology Market in Canada: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019 |
| Canadian Assisted Reproductive Technology Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| JAPAN |
| Japanese Market for Assisted Reproductive Technology: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2020-2027 |
| Assisted Reproductive Technology Market in Japan: Historic Sales Analysis in US$ Million by Segment for the Period 2012-2019 |
| Japanese Assisted Reproductive Technology Market Share Analysis by Segment: 2012 VS 2020 VS 2027 |
| Japanese Demand Estimates and Forecasts for Assisted Reproductive Technology in US$ Million by End-Use: 2020 to 2027 |
| Japanese Assisted Reproductive Technology Market in US$ Million by End-Use: 2012-2019 |
| Assisted Reproductive Technology Market Share Shift in Japan by End-Use: 2012 VS 2020 VS 2027 |
| CHINA |
| Chinese Assisted Reproductive Technology Market Growth Prospects in US$ Million by Segment for the Period 2020-2027 |
| Assisted Reproductive Technology Historic Market Analysis in China in US$ Million by Segment: 2012-2019 |
| Chinese Assisted Reproductive Technology Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Chinese Demand for Assisted Reproductive Technology in US$ Million by End-Use: 2020 to 2027 |
| Assisted Reproductive Technology Market Review in China in US$ Million by End-Use: 2012-2019 |
| Chinese Assisted Reproductive Technology Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 |
| EUROPE |
| Market Facts & Figures |
| European Assisted Reproductive Technology Market: Competitor Market Share Scenario (in %) for 2019 & 2025 |
| European Assisted Reproductive Technology Market Demand Scenario in US$ Million by Region/Country: 2020-2027 |
| Assisted Reproductive Technology Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012-2019 |
| European Assisted Reproductive Technology Market Share Shift by Region/Country: 2012 VS 2020 VS 2027 |
| European Assisted Reproductive Technology Market Estimates and Forecasts in US$ Million by Segment: 2020-2027 |
| Assisted Reproductive Technology Market in Europe in US$ Million by Segment: A Historic Review for the Period 2012-2019 |
| European Assisted Reproductive Technology Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| European Assisted Reproductive Technology Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 |
| Assisted Reproductive Technology Market in Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019 |
| European Assisted Reproductive Technology Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| FRANCE |
| Assisted Reproductive Technology Market in France by Segment: Estimates and Projections in US$ Million for the Period 2020-2027 |
| French Assisted Reproductive Technology Historic Market Scenario in US$ Million by Segment: 2012-2019 |
| French Assisted Reproductive Technology Market Share Analysis by Segment: 2012 VS 2020 VS 2027 |
| Assisted Reproductive Technology Quantitative Demand Analysis in France in US$ Million by End-Use: 2020-2027 |
| French Assisted Reproductive Technology Historic Market Review in US$ Million by End-Use: 2012-2019 |
| French Assisted Reproductive Technology Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 |
| GERMANY |
| Assisted Reproductive Technology Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Segment for the Period 2020-2027 |
| German Assisted Reproductive Technology Historic Market Analysis in US$ Million by Segment: 2012-2019 |
| German Assisted Reproductive Technology Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| Assisted Reproductive Technology Market in Germany: Annual Sales Estimates and Forecasts in US$ Million by End-Use for the Period 2020-2027 |
| German Assisted Reproductive Technology Market in Retrospect in US$ Million by End-Use: 2012-2019 |
| Assisted Reproductive Technology Market Share Distribution in Germany by End-Use: 2012 VS 2020 VS 2027 |
| ITALY |
| Italian Assisted Reproductive Technology Market Growth Prospects in US$ Million by Segment for the Period 2020-2027 |
| Assisted Reproductive Technology Historic Market Analysis in Italy in US$ Million by Segment: 2012-2019 |
| Italian Assisted Reproductive Technology Market by Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027 |
| Italian Demand for Assisted Reproductive Technology in US$ Million by End-Use: 2020 to 2027 |
| Assisted Reproductive Technology Market Review in Italy in US$ Million by End-Use: 2012-2019 |
| Italian Assisted Reproductive Technology Market Share Breakdown by End-Use: 2012 VS 2020 VS 2027 |
| UNITED KINGDOM |
| United Kingdom Market for Assisted Reproductive Technology: Annual Sales Estimates and Projections in US$ Million by Segment for the Period 2020-2027 |
| Assisted Reproductive Technology Market in the United Kingdom: Historic Sales Analysis in US$ Million by Segment for the Period 2012-2019 |
| United Kingdom Assisted Reproductive Technology Market Share Analysis by Segment: 2012 VS 2020 VS 2027 |
| United Kingdom Demand Estimates and Forecasts for Assisted Reproductive Technology in US$ Million by End-Use: 2020 to 2027 |
| United Kingdom Assisted Reproductive Technology Market in US$ Million by End-Use: 2012-2019 |
| Assisted Reproductive Technology Market Share Shift in the United Kingdom by End-Use: 2012 VS 2020 VS 2027 |
| REST OF EUROPE |
| Rest of Europe Assisted Reproductive Technology Market Estimates and Forecasts in US$ Million by Segment: 2020-2027 |
| Assisted Reproductive Technology Market in Rest of Europe in US$ Million by Segment: A Historic Review for the Period 2012-2019 |
| Rest of Europe Assisted Reproductive Technology Market Share Breakdown by Segment: 2012 VS 2020 VS 2027 |
| Rest of Europe Assisted Reproductive Technology Addressable Market Opportunity in US$ Million by End-Use: 2020-2027 |
| Assisted Reproductive Technology Market in Rest of Europe: Summarization of Historic Demand in US$ Million by End-Use for the Period 2012-2019 |
| Rest of Europe Assisted Reproductive Technology Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| ASIA-PACIFIC |
| Assisted Reproductive Technology Market in Asia-Pacific by Segment: Estimates and Projections in US$ Million for the Period 2020-2027 |
| Asia-Pacific Assisted Reproductive Technology Historic Market Scenario in US$ Million by Segment: 2012-2019 |
| Asia-Pacific Assisted Reproductive Technology Market Share Analysis by Segment: 2012 VS 2020 VS 2027 |
| Assisted Reproductive Technology Quantitative Demand Analysis in Asia-Pacific in US$ Million by End-Use: 2020-2027 |
| Asia-Pacific Assisted Reproductive Technology Historic Market Review in US$ Million by End-Use: 2012-2019 |
| Asia-Pacific Assisted Reproductive Technology Market Share Analysis: A 17-Year Perspective by End-Use for 2012, 2020, and 2027 |
| REST OF WORLD |
| Rest of World Assisted Reproductive Technology Market Estimates and Forecasts in US$ Million by Segment: 2020 to 2027 |
| Rest of World Assisted Reproductive Technology Historic Market Review by Segment in US$ Million: 2012-2019 |
| Assisted Reproductive Technology Market in Rest of World: Percentage Share Breakdown of Sales by Segment for 2012, 2020, and 2027 |
| Rest of World Assisted Reproductive Technology Market Quantitative Demand Analysis in US$ Million by End-Use: 2020 to 2027 |
| Assisted Reproductive Technology Market in Rest of World: Summarization of Historic Demand Patterns in US$ Million by End-Use for 2012-2019 |
| Rest of World Assisted Reproductive Technology Market Share Analysis by End-Use: 2012 VS 2020 VS 2027 |
| IV. COMPETITION |
| Total Companies Profiled : 44 Click here to request a full table of contents and more details on this project. |
| V. CURATED RESEARCH |
INSIDER ACCESS TO
METHODOLOGY
QUESTIONNAIRE
INFLUENCER NETWORK
Registration is required to access our data stacks.
RESEARCH PANEL
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.
- Complimentary previews of full stack research data for participated
- Insider access to research programs including engagements and stats from other panelists
- Unlimited research credits of $1000 per participated project
- Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
- Interact with other panelists via our MarketGlassTM Data Exchange Platform*
- BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*
* Complete details will be shared with panelists upon formal acceptance.
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com